Structure

Physi-Chem Properties

Molecular Weight:  201.09
Volume:  201.741
LogP:  0.715
LogD:  1.41
LogS:  -2.589
# Rotatable Bonds:  0
TPSA:  63.54
# H-Bond Aceptor:  4
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.503
Synthetic Accessibility Score:  3.657
Fsp3:  0.182
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.899
MDCK Permeability:  8.660327694087755e-06
Pgp-inhibitor:  0.0
Pgp-substrate:  0.956
Human Intestinal Absorption (HIA):  0.011
20% Bioavailability (F20%):  0.992
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.619
Plasma Protein Binding (PPB):  79.37791442871094%
Volume Distribution (VD):  1.678
Pgp-substrate:  27.075984954833984%

ADMET: Metabolism

CYP1A2-inhibitor:  0.975
CYP1A2-substrate:  0.834
CYP2C19-inhibitor:  0.062
CYP2C19-substrate:  0.316
CYP2C9-inhibitor:  0.106
CYP2C9-substrate:  0.444
CYP2D6-inhibitor:  0.313
CYP2D6-substrate:  0.859
CYP3A4-inhibitor:  0.065
CYP3A4-substrate:  0.15

ADMET: Excretion

Clearance (CL):  8.346
Half-life (T1/2):  0.6

ADMET: Toxicity

hERG Blockers:  0.008
Human Hepatotoxicity (H-HT):  0.406
Drug-inuced Liver Injury (DILI):  0.856
AMES Toxicity:  0.916
Rat Oral Acute Toxicity:  0.23
Maximum Recommended Daily Dose:  0.509
Skin Sensitization:  0.801
Carcinogencity:  0.945
Eye Corrosion:  0.004
Eye Irritation:  0.461
Respiratory Toxicity:  0.917

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC100726

Natural Product ID:  NPC100726
Common Name*:   Makaluvamine A
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  RUIRYCQUTHWLMZ-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C11H11N3O/c1-14-5-6-2-3-13-8-4-7(12)11(15)10(14)9(6)8/h4-5H,2-3,12H2,1H3
SMILES:  Cn1cc2CCN=C3C=C(C(=O)c1c23)N
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL449905
PubChem CID:   4002
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0001253] Quinolines and derivatives
        • [CHEMONTID:0001734] Pyrroloquinolines
          • [CHEMONTID:0002829] Pyrrolo[4,3,2-de]quinolines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32549 zyzzya fuliginosa Species n.a. Eukaryota n.a. indopacific n.a. PMID[12027767]
NPO32549 zyzzya fuliginosa Species n.a. Eukaryota n.a. n.a. n.a. PMID[16180829]
NPO32549 zyzzya fuliginosa Species n.a. Eukaryota n.a. pohnpeian n.a. PMID[8691207]
NPO32467 zyzzya fuliginosus Species n.a. Eukaryota n.a. n.a. n.a. PMID[8946754]
NPO32549 zyzzya fuliginosa Species n.a. Eukaryota n.a. n.a. n.a. PMID[9134749]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT168 Cell Line P388 Mus musculus ED50 = 0.4 ug ml-1 PMID[514008]
NPT1044 Individual Protein DNA topoisomerase II alpha Homo sapiens IC90 = 41000.0 nM PMID[514010]
NPT393 Cell Line HCT-116 Homo sapiens IC50 > 170.0 nM PMID[514010]
NPT6399 Cell Line XRS6 Cricetulus griseus IC50 = 80.0 nM PMID[514010]
NPT2 Others Unspecified IC50 = 5000.0 nM PMID[514009]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC100726 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9441 High Similarity NPC471655
0.9441 High Similarity NPC473878
0.9371 High Similarity NPC102664
0.898 High Similarity NPC470679
0.898 High Similarity NPC217021
0.875 High Similarity NPC470680
0.875 High Similarity NPC100104
0.8562 High Similarity NPC474492
0.8467 Intermediate Similarity NPC123906
0.8421 Intermediate Similarity NPC251391
0.8395 Intermediate Similarity NPC182940
0.8365 Intermediate Similarity NPC262338
0.8289 Intermediate Similarity NPC313889
0.8267 Intermediate Similarity NPC467188
0.8235 Intermediate Similarity NPC70406
0.8107 Intermediate Similarity NPC268966
0.8061 Intermediate Similarity NPC79777
0.8061 Intermediate Similarity NPC234403
0.805 Intermediate Similarity NPC274981
0.8039 Intermediate Similarity NPC105811
0.8023 Intermediate Similarity NPC93390
0.7975 Intermediate Similarity NPC80681
0.7931 Intermediate Similarity NPC473814
0.7931 Intermediate Similarity NPC78767
0.7905 Intermediate Similarity NPC291517
0.7898 Intermediate Similarity NPC209362
0.7885 Intermediate Similarity NPC472260
0.7844 Intermediate Similarity NPC477042
0.7818 Intermediate Similarity NPC469529
0.7808 Intermediate Similarity NPC71236
0.78 Intermediate Similarity NPC472288
0.7778 Intermediate Similarity NPC477415
0.7778 Intermediate Similarity NPC23476
0.7778 Intermediate Similarity NPC474259
0.7759 Intermediate Similarity NPC473821
0.7709 Intermediate Similarity NPC106757
0.7688 Intermediate Similarity NPC475874
0.7673 Intermediate Similarity NPC229055
0.7669 Intermediate Similarity NPC233380
0.7633 Intermediate Similarity NPC73994
0.763 Intermediate Similarity NPC473628
0.7627 Intermediate Similarity NPC74153
0.7625 Intermediate Similarity NPC74357
0.7624 Intermediate Similarity NPC88115
0.7619 Intermediate Similarity NPC284775
0.7619 Intermediate Similarity NPC83774
0.7588 Intermediate Similarity NPC191415
0.7578 Intermediate Similarity NPC213914
0.7576 Intermediate Similarity NPC70949
0.7557 Intermediate Similarity NPC225622
0.7557 Intermediate Similarity NPC477414
0.7557 Intermediate Similarity NPC221726
0.7542 Intermediate Similarity NPC474767
0.7529 Intermediate Similarity NPC61011
0.7514 Intermediate Similarity NPC469359
0.75 Intermediate Similarity NPC477003
0.75 Intermediate Similarity NPC265100
0.7472 Intermediate Similarity NPC292361
0.7451 Intermediate Similarity NPC65408
0.7434 Intermediate Similarity NPC23215
0.743 Intermediate Similarity NPC167710
0.7412 Intermediate Similarity NPC157583
0.7412 Intermediate Similarity NPC237188
0.741 Intermediate Similarity NPC114637
0.7401 Intermediate Similarity NPC216550
0.7399 Intermediate Similarity NPC46895
0.7383 Intermediate Similarity NPC313823
0.7381 Intermediate Similarity NPC302647
0.7333 Intermediate Similarity NPC242116
0.7294 Intermediate Similarity NPC186068
0.7289 Intermediate Similarity NPC478184
0.7284 Intermediate Similarity NPC281094
0.7263 Intermediate Similarity NPC304203
0.7253 Intermediate Similarity NPC81535
0.7247 Intermediate Similarity NPC476460
0.7246 Intermediate Similarity NPC42372
0.7246 Intermediate Similarity NPC115232
0.7241 Intermediate Similarity NPC102755
0.7232 Intermediate Similarity NPC103119
0.7216 Intermediate Similarity NPC118084
0.7212 Intermediate Similarity NPC293487
0.7198 Intermediate Similarity NPC477041
0.7198 Intermediate Similarity NPC477044
0.7193 Intermediate Similarity NPC293216
0.7191 Intermediate Similarity NPC469489
0.7186 Intermediate Similarity NPC478182
0.7168 Intermediate Similarity NPC11126
0.7167 Intermediate Similarity NPC326422
0.7159 Intermediate Similarity NPC295158
0.7143 Intermediate Similarity NPC106824
0.7143 Intermediate Similarity NPC182570
0.7143 Intermediate Similarity NPC265605
0.7143 Intermediate Similarity NPC48564
0.7104 Intermediate Similarity NPC476143
0.7101 Intermediate Similarity NPC41717
0.709 Intermediate Similarity NPC61038
0.7079 Intermediate Similarity NPC473946
0.7068 Intermediate Similarity NPC477413
0.7065 Intermediate Similarity NPC477045
0.7065 Intermediate Similarity NPC284338
0.7062 Intermediate Similarity NPC311282
0.7044 Intermediate Similarity NPC58268
0.7044 Intermediate Similarity NPC129412
0.7044 Intermediate Similarity NPC114033
0.7044 Intermediate Similarity NPC101130
0.7041 Intermediate Similarity NPC71132
0.7039 Intermediate Similarity NPC471589
0.7039 Intermediate Similarity NPC255909
0.7033 Intermediate Similarity NPC202812
0.7025 Intermediate Similarity NPC110126
0.7024 Intermediate Similarity NPC478185
0.7018 Intermediate Similarity NPC471943
0.7017 Intermediate Similarity NPC47190
0.7017 Intermediate Similarity NPC472292
0.7011 Intermediate Similarity NPC14113
0.7011 Intermediate Similarity NPC145885
0.7011 Intermediate Similarity NPC84827
0.7006 Intermediate Similarity NPC228835
0.7005 Intermediate Similarity NPC317701
0.7005 Intermediate Similarity NPC138562
0.7 Intermediate Similarity NPC190296
0.7 Intermediate Similarity NPC27740
0.7 Intermediate Similarity NPC56233
0.7 Intermediate Similarity NPC136002
0.7 Intermediate Similarity NPC478183
0.6995 Remote Similarity NPC472293
0.6989 Remote Similarity NPC470677
0.6981 Remote Similarity NPC238499
0.6973 Remote Similarity NPC477004
0.6973 Remote Similarity NPC237414
0.6968 Remote Similarity NPC477043
0.6968 Remote Similarity NPC330326
0.6966 Remote Similarity NPC133003
0.6966 Remote Similarity NPC474258
0.6964 Remote Similarity NPC473706
0.6954 Remote Similarity NPC151635
0.6952 Remote Similarity NPC472062
0.6952 Remote Similarity NPC472063
0.6952 Remote Similarity NPC472069
0.6949 Remote Similarity NPC159125
0.6947 Remote Similarity NPC143075
0.6944 Remote Similarity NPC75544
0.6944 Remote Similarity NPC209917
0.6943 Remote Similarity NPC195704
0.6943 Remote Similarity NPC14448
0.6943 Remote Similarity NPC167200
0.6943 Remote Similarity NPC200397
0.6943 Remote Similarity NPC138596
0.6943 Remote Similarity NPC64661
0.6943 Remote Similarity NPC292434
0.6943 Remote Similarity NPC207866
0.6943 Remote Similarity NPC98156
0.694 Remote Similarity NPC135950
0.6936 Remote Similarity NPC252572
0.6931 Remote Similarity NPC175602
0.6919 Remote Similarity NPC91895
0.6919 Remote Similarity NPC34837
0.6919 Remote Similarity NPC32534
0.6918 Remote Similarity NPC291389
0.6918 Remote Similarity NPC471574
0.6918 Remote Similarity NPC73767
0.6915 Remote Similarity NPC476252
0.6914 Remote Similarity NPC314372
0.691 Remote Similarity NPC467063
0.6902 Remote Similarity NPC128244
0.6899 Remote Similarity NPC105127
0.6899 Remote Similarity NPC150259
0.6899 Remote Similarity NPC84911
0.6895 Remote Similarity NPC469577
0.6895 Remote Similarity NPC475410
0.6882 Remote Similarity NPC103361
0.6882 Remote Similarity NPC123395
0.6882 Remote Similarity NPC472296
0.6882 Remote Similarity NPC472297
0.6879 Remote Similarity NPC249614
0.6878 Remote Similarity NPC469563
0.6875 Remote Similarity NPC12649
0.6875 Remote Similarity NPC248041
0.6875 Remote Similarity NPC126709
0.6872 Remote Similarity NPC99939
0.6872 Remote Similarity NPC308931
0.6862 Remote Similarity NPC57398
0.6857 Remote Similarity NPC267885
0.6845 Remote Similarity NPC121327
0.6842 Remote Similarity NPC2414
0.6842 Remote Similarity NPC472065
0.6842 Remote Similarity NPC472064
0.6835 Remote Similarity NPC261195
0.6835 Remote Similarity NPC29886
0.6835 Remote Similarity NPC96102
0.6821 Remote Similarity NPC65080
0.6818 Remote Similarity NPC473380
0.6818 Remote Similarity NPC240088
0.6813 Remote Similarity NPC324091
0.6813 Remote Similarity NPC154339
0.681 Remote Similarity NPC159856
0.6803 Remote Similarity NPC476566
0.68 Remote Similarity NPC139763
0.68 Remote Similarity NPC149155
0.68 Remote Similarity NPC110500

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC100726 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7738 Intermediate Similarity NPD1291 Clinical (unspecified phase)
0.7669 Intermediate Similarity NPD1568 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD1627 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD1270 Approved
0.75 Intermediate Similarity NPD3607 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD200 Phase 2
0.7451 Intermediate Similarity NPD201 Phase 2
0.7434 Intermediate Similarity NPD272 Approved
0.7423 Intermediate Similarity NPD1630 Approved
0.7374 Intermediate Similarity NPD4848 Phase 1
0.7371 Intermediate Similarity NPD4988 Discontinued
0.7365 Intermediate Similarity NPD1343 Approved
0.7355 Intermediate Similarity NPD569 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD4524 Discontinued
0.7294 Intermediate Similarity NPD4736 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD1631 Approved
0.7283 Intermediate Similarity NPD4011 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD5400 Approved
0.7209 Intermediate Similarity NPD2753 Discontinued
0.7184 Intermediate Similarity NPD3178 Discontinued
0.7174 Intermediate Similarity NPD5017 Discontinued
0.7151 Intermediate Similarity NPD3238 Discontinued
0.7143 Intermediate Similarity NPD270 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD271 Approved
0.7143 Intermediate Similarity NPD268 Approved
0.7135 Intermediate Similarity NPD750 Phase 2
0.7126 Intermediate Similarity NPD1643 Phase 3
0.7125 Intermediate Similarity NPD175 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD4426 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD1573 Approved
0.7118 Intermediate Similarity NPD1575 Approved
0.7089 Intermediate Similarity NPD9599 Approved
0.7073 Intermediate Similarity NPD180 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD751 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD3475 Approved
0.7059 Intermediate Similarity NPD3476 Approved
0.7059 Intermediate Similarity NPD1292 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD6180 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD7401 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD5965 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD9343 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD7564 Discontinued
0.7 Intermediate Similarity NPD9357 Approved
0.7 Intermediate Similarity NPD5686 Approved
0.7 Intermediate Similarity NPD4643 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD5685 Approved
0.6994 Remote Similarity NPD1586 Approved
0.6988 Remote Similarity NPD276 Clinical (unspecified phase)
0.6978 Remote Similarity NPD460 Discontinued
0.6974 Remote Similarity NPD2118 Approved
0.6974 Remote Similarity NPD992 Clinical (unspecified phase)
0.6974 Remote Similarity NPD991 Phase 2
0.6974 Remote Similarity NPD2119 Approved
0.6968 Remote Similarity NPD9100 Approved
0.6935 Remote Similarity NPD8248 Clinical (unspecified phase)
0.6933 Remote Similarity NPD1004 Phase 2
0.6933 Remote Similarity NPD1005 Phase 2
0.6932 Remote Similarity NPD3927 Phase 2
0.6932 Remote Similarity NPD5473 Discontinued
0.6928 Remote Similarity NPD1031 Discontinued
0.6927 Remote Similarity NPD5820 Clinical (unspecified phase)
0.6908 Remote Similarity NPD9583 Approved
0.6906 Remote Similarity NPD1905 Clinical (unspecified phase)
0.6905 Remote Similarity NPD2214 Approved
0.6905 Remote Similarity NPD2213 Approved
0.6902 Remote Similarity NPD2289 Phase 3
0.6902 Remote Similarity NPD2290 Phase 3
0.6893 Remote Similarity NPD1783 Clinical (unspecified phase)
0.689 Remote Similarity NPD3100 Discontinued
0.6882 Remote Similarity NPD1545 Discontinued
0.6878 Remote Similarity NPD3947 Discontinued
0.6878 Remote Similarity NPD4299 Phase 1
0.6875 Remote Similarity NPD1587 Approved
0.6867 Remote Similarity NPD748 Clinical (unspecified phase)
0.6864 Remote Similarity NPD6454 Clinical (unspecified phase)
0.6862 Remote Similarity NPD4924 Clinical (unspecified phase)
0.6857 Remote Similarity NPD4075 Phase 2
0.6857 Remote Similarity NPD749 Clinical (unspecified phase)
0.6836 Remote Similarity NPD2479 Phase 3
0.6836 Remote Similarity NPD2481 Approved
0.6835 Remote Similarity NPD198 Clinical (unspecified phase)
0.6828 Remote Similarity NPD7204 Clinical (unspecified phase)
0.6826 Remote Similarity NPD2061 Approved
0.6823 Remote Similarity NPD1600 Suspended
0.6816 Remote Similarity NPD1096 Discontinued
0.6815 Remote Similarity NPD4028 Approved
0.6815 Remote Similarity NPD4030 Approved
0.6815 Remote Similarity NPD4029 Approved
0.6813 Remote Similarity NPD786 Approved
0.6802 Remote Similarity NPD6446 Discontinued
0.6802 Remote Similarity NPD4174 Clinical (unspecified phase)
0.68 Remote Similarity NPD482 Approved
0.6796 Remote Similarity NPD2770 Discontinued
0.6789 Remote Similarity NPD6288 Clinical (unspecified phase)
0.6784 Remote Similarity NPD3583 Phase 2
0.6782 Remote Similarity NPD3347 Clinical (unspecified phase)
0.6782 Remote Similarity NPD485 Clinical (unspecified phase)
0.6776 Remote Similarity NPD2336 Approved
0.6774 Remote Similarity NPD1952 Discontinued
0.6757 Remote Similarity NPD9396 Approved
0.6757 Remote Similarity NPD9392 Approved
0.6754 Remote Similarity NPD2008 Discontinued
0.6739 Remote Similarity NPD4922 Phase 2
0.6736 Remote Similarity NPD7704 Clinical (unspecified phase)
0.673 Remote Similarity NPD206 Clinical (unspecified phase)
0.6728 Remote Similarity NPD1722 Approved
0.6728 Remote Similarity NPD5020 Approved
0.6727 Remote Similarity NPD4702 Approved
0.6727 Remote Similarity NPD4703 Approved
0.6727 Remote Similarity NPD4547 Phase 3
0.6725 Remote Similarity NPD6771 Discontinued
0.672 Remote Similarity NPD1851 Clinical (unspecified phase)
0.6709 Remote Similarity NPD3942 Approved
0.6709 Remote Similarity NPD3944 Approved
0.6705 Remote Similarity NPD4883 Approved
0.6702 Remote Similarity NPD5901 Discontinued
0.6702 Remote Similarity NPD6137 Clinical (unspecified phase)
0.6701 Remote Similarity NPD4851 Clinical (unspecified phase)
0.6687 Remote Similarity NPD4374 Clinical (unspecified phase)
0.6685 Remote Similarity NPD1658 Discontinued
0.6684 Remote Similarity NPD2881 Approved
0.6684 Remote Similarity NPD2879 Approved
0.6667 Remote Similarity NPD3654 Approved
0.6648 Remote Similarity NPD5809 Phase 3
0.6647 Remote Similarity NPD2915 Discontinued
0.6646 Remote Similarity NPD2896 Discontinued
0.6633 Remote Similarity NPD2411 Approved
0.6632 Remote Similarity NPD3839 Phase 2
0.6632 Remote Similarity NPD3840 Phase 2
0.6632 Remote Similarity NPD1506 Discontinued
0.6631 Remote Similarity NPD2307 Discontinued
0.663 Remote Similarity NPD3871 Clinical (unspecified phase)
0.663 Remote Similarity NPD3870 Clinical (unspecified phase)
0.6622 Remote Similarity NPD269 Clinical (unspecified phase)
0.6615 Remote Similarity NPD6987 Phase 1
0.6614 Remote Similarity NPD2405 Phase 3
0.6613 Remote Similarity NPD4348 Clinical (unspecified phase)
0.6612 Remote Similarity NPD3246 Discontinued
0.6612 Remote Similarity NPD3961 Discontinued
0.6604 Remote Similarity NPD3385 Approved
0.6599 Remote Similarity NPD6787 Phase 2
0.6598 Remote Similarity NPD6459 Phase 2
0.659 Remote Similarity NPD5088 Discontinued
0.6585 Remote Similarity NPD2006 Phase 2
0.6582 Remote Similarity NPD803 Phase 1
0.6582 Remote Similarity NPD6152 Phase 1
0.658 Remote Similarity NPD3967 Approved
0.6578 Remote Similarity NPD7618 Phase 3
0.6578 Remote Similarity NPD7619 Phase 3
0.6575 Remote Similarity NPD2095 Phase 2
0.6575 Remote Similarity NPD5728 Clinical (unspecified phase)
0.6575 Remote Similarity NPD2092 Phase 2
0.6575 Remote Similarity NPD3318 Approved
0.6575 Remote Similarity NPD3319 Phase 1
0.6575 Remote Similarity NPD2094 Phase 2
0.6575 Remote Similarity NPD3320 Approved
0.6573 Remote Similarity NPD6044 Discontinued
0.6573 Remote Similarity NPD4385 Clinical (unspecified phase)
0.6573 Remote Similarity NPD7402 Clinical (unspecified phase)
0.6571 Remote Similarity NPD4638 Approved
0.6571 Remote Similarity NPD4639 Approved
0.6571 Remote Similarity NPD4640 Approved
0.6568 Remote Similarity NPD2837 Discontinued
0.6564 Remote Similarity NPD107 Approved
0.6557 Remote Similarity NPD4940 Approved
0.6546 Remote Similarity NPD3905 Phase 3
0.6543 Remote Similarity NPD7027 Phase 3
0.6538 Remote Similarity NPD1598 Discontinued
0.6538 Remote Similarity NPD2096 Phase 2
0.6538 Remote Similarity NPD721 Approved
0.6538 Remote Similarity NPD2091 Phase 2
0.6536 Remote Similarity NPD5755 Clinical (unspecified phase)
0.6533 Remote Similarity NPD2412 Clinical (unspecified phase)
0.6531 Remote Similarity NPD7998 Clinical (unspecified phase)
0.6528 Remote Similarity NPD3247 Clinical (unspecified phase)
0.6519 Remote Similarity NPD715 Phase 3
0.6515 Remote Similarity NPD5888 Phase 2
0.6513 Remote Similarity NPD2509 Approved
0.6513 Remote Similarity NPD2510 Approved
0.6509 Remote Similarity NPD510 Phase 1
0.6503 Remote Similarity NPD2073 Approved
0.6503 Remote Similarity NPD4336 Clinical (unspecified phase)
0.6503 Remote Similarity NPD2070 Approved
0.6503 Remote Similarity NPD2072 Approved
0.6503 Remote Similarity NPD768 Clinical (unspecified phase)
0.6503 Remote Similarity NPD2071 Approved
0.6503 Remote Similarity NPD2069 Approved
0.6503 Remote Similarity NPD2074 Approved
0.6503 Remote Similarity NPD2075 Approved
0.6503 Remote Similarity NPD2068 Approved
0.6497 Remote Similarity NPD4614 Clinical (unspecified phase)
0.6495 Remote Similarity NPD7289 Clinical (unspecified phase)
0.6491 Remote Similarity NPD2580 Discontinued
0.6489 Remote Similarity NPD7024 Clinical (unspecified phase)
0.6488 Remote Similarity NPD2430 Phase 2
0.6486 Remote Similarity NPD7175 Phase 1
0.6486 Remote Similarity NPD6068 Discontinued
0.6485 Remote Similarity NPD4637 Clinical (unspecified phase)
0.6485 Remote Similarity NPD2007 Clinical (unspecified phase)
0.6485 Remote Similarity NPD3717 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data